HYPERKALEMIA
Clinical trials for HYPERKALEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERKALEMIA trials appear
Sign up with your email to follow new studies for HYPERKALEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Less insulin may be just as effective for high potassium
Disease control CompletedThis study tested whether a lower dose of insulin (5 units) works as well as the standard dose (10 units) for lowering dangerously high potassium levels in adults. Researchers enrolled 384 patients with potassium levels of 5.5 mEq/L or higher. The goal was to see if the smaller d…
Matched conditions: HYPERKALEMIA
Phase: PHASE4 • Sponsor: Oman Medical Speciality Board • Aim: Disease control
Last updated May 26, 2026 08:28 UTC
-
Nurse teaching cuts heart risk for kidney patients
Disease control CompletedThis study tested if a nurse-led nutrition class could help dialysis patients with high potassium, a dangerous heart risk. Thirty adults on hemodialysis in Morocco, where dietitians are scarce, took part. After 12 weeks, more patients had safe potassium levels, showing this simpl…
Matched conditions: HYPERKALEMIA
Phase: NA • Sponsor: HASSAN 1st university • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
Lokelma allows higher heart med doses in kidney patients
Disease control CompletedThis study tested whether a drug called Lokelma (SZC) can help people with both heart failure and chronic kidney disease safely take higher doses of standard heart medications (RAAS inhibitors) without dangerous potassium spikes. 112 adults with stable kidney disease and high-nor…
Matched conditions: HYPERKALEMIA
Phase: PHASE3 • Sponsor: St George's, University of London • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New drug shows promise for dangerous potassium levels in kidney patients
Disease control CompletedThis study tested a medicine called patiromer in 262 Chinese adults with chronic kidney disease and high potassium levels. The goal was to see if patiromer could safely lower potassium and help patients stay on important heart and kidney medications. Participants first received p…
Matched conditions: HYPERKALEMIA
Phase: PHASE3 • Sponsor: Vifor Fresenius Medical Care Renal Pharma • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Which treatment works best for dangerous potassium levels? large trial reveals answers
Disease control CompletedThis study tested three emergency treatments for dangerously high potassium levels (hyperkalemia) in 419 adults at emergency departments. It compared insulin/dextrose infusion, nebulized salbutamol, and a combination of both to see which lowers potassium most effectively within 6…
Matched conditions: HYPERKALEMIA
Phase: PHASE4 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Wearable ECG could warn dialysis patients of hidden heart danger
Knowledge-focused CompletedThis study tested whether a small, wearable ECG device can detect high potassium levels (hyperkalemia) in people on dialysis. Thirty-two adults with chronic kidney disease wore the sensor during dialysis sessions over six weeks. Researchers compared ECG readings with blood test r…
Matched conditions: HYPERKALEMIA
Sponsor: Kyungho Park • Aim: Knowledge-focused
Last updated May 26, 2026 08:35 UTC